Netherlands· NL-5be245ac6f16
Detrusitol 1 mg, filmomhulde tabletten
A tolterodine product containing tolterodinetartraat, registered in Netherlands by Viatris Healthcare Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tolterodine is registered in 16 of 19 countries.
Countries holding a registration under ATC G04BD07 (tolterodine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Tolterodine · ATC G04BD07
16 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tolterodine costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.70 in Italy to $1.95 in Switzerland — a ×2.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tolterodine · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.95
- ES Spain$1.16
- IT Italy$0.70
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TOLTERODINETARTRAAT
- Manufacturer
- Viatris Healthcare Limited
- Country
- Netherlands (NL)
- ATC code
- G04BD07
- ATC class
- Tolterodine
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id22148
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
324 interactions on record for tolterodine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolterodine · interactions on record
324 records
- 3 severe
- 129 moderate
- 33 minor
- 152 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- ClotrimazoleA01AB18moderate
7 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tolterodine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDetrolViatris Specialty LLC
- FinlandDetrusitolViatris Healthcare Limited
- SwedenDetrusitol 1 mg Filmdragerad tablettViatris Healthcare Limited
- PolandRanolterilAccord Healthcare Polska Sp. z o.o.
- IrelandDetrusitol 1 mg film-coated tabletsViatris Healthcare Limited
- BelgiumDetrusitol 1 mgViatris Healthcare
- United KingdomBlerone XL 4mg capsulesZentiva Pharma UK Ltd
- SpainDETRUSITOL 2 mg COMPRIMIDOS RECUBIERTOS CON PELICULAFarmasierra Laboratorios S.L.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Detrusitol, Tolterodin Accord
- Belgium · Detrusitol, Detrusitol Retard
- Bulgaria · Толтеродин Акорд
- Cyprus · Detrusitol, Tolterana
- Germany · Detrusitol, Detrusitol Retard
- Denmark · Detrusitol Retard, Tolterodin Rivopharm
- Estonia · Uroflow
- Spain · Detrusitol, Detrusitol Neo
- Finland · Detrusitol, Detrusitol Sr
- France · Detrusitol
- United Kingdom (Northern Ireland) · Blerone Xl, Caristenol
- Greece · Cinterol, Detrusitol
- Ireland · Detrusitol, Detrusitol Sr
- Iceland · Detrusitol Retard, Tolterodin Actavis
- Italy · Detrusitol, Detrusitol Retard
- Lithuania · Detrusitol, Detrusitol Sr
- Luxembourg · Detrusitol, Detrusitol Retard
- Latvia · Uroflow
- Norway · Detrusitol Sr, Tolterodine Sandoz
- Poland · Defur, Titlodine
- Romania · Uroflow
- Sweden · Detrusitol, Detrusitol Sr
- Slovenia · Detrusitol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/37dd455c-1990-4714-b507-40685e25e03b GET /v1/drugs/37dd455c-1990-4714-b507-40685e25e03b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h22148_smpc.pdf",
"strength": null,
"atc_label": "Tolterodine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg22148",
"excipients": [
"CALCIUMWATERSTOFFOSFAAT 2-WATER (E 341)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE (E 464)",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT",
"SILICIUMDIOXIDE (E 551)",
"STEARINEZUUR (E 570)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"TOLTERODINETARTRAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h22148.pdf",
"authorised_at": "1998/02/17",
"procedure_number": "SE/H/0139/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "22148",
"additional_monitoring": "N"
}See everything about tolterodine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.